nach oben

Erschienen in:

01.01.2014 | Original Paper

Review of Community Pharmacy Staff Educational Needs for Supporting Mental Health Consumers and Carers

verfasst von: Amary Mey, Jane L. Fowler, Kathy Knox, David H. K. Shum, Jasmina Fejzic, Laetitia Hattingh, Denise McConnell, Amanda Wheeler

Erschienen in: Community Mental Health Journal | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Development of a mental health education package for community pharmacy staff should be informed by mental health consumers/carers’ needs, expectations and experiences, and staff knowledge, skills and attitudes. This review (1) explored research on community pharmacy practice and service provision for mental health consumers/carers, and (2) identified validated methods for assessing staff knowledge, skills and attitudes about mental illness to inform the development of a training questionnaire. A literature scan using key words knowledge, skills, attitudes, and beliefs combined with community pharmacy, pharmacist, and pharmacy support staff, and mental illness, depression, anxiety was conducted. A small number of studies were found that used reliable methods to assess pharmacists’ training needs regarding mental illness and treatment options. There was little published specifically in relation to depression and anxiety in community pharmacy practice. No studies assessed the training needs of pharmacy support staff. A systematic analysis of pharmacy staff learning needs is warranted.

Adler, D. A., Bungay, K. M., Wilson, I. B., Pei, Y., Supran, S., Peckham, E., et al. (2004). The impact of a pharmacist intervention on 6-month outcomes in depressed primary care patients. General Hospital Psychiatry, 26(3), 199–209.PubMedCrossRef

Angermeyer, M. C., & Dietrich, S. (2006). Public beliefs about and attitudes towards people with mental illness: A review of population studies. Acta Psychiatrica Scandinavica, 113(3), 163–179.PubMedCrossRef

Angermeyer, M. C., & Matschinger, H. (2003). The stigma of mental illness: Effect of labelling on public attitudes towards people with mental disorders. Acta Psychiatrica Scandinavica, 108, 304–309.PubMedCrossRef

Australian Institute of Health and Welfare. (2010a). Australia’s health 2010. Retrieved January 30, 2012, from http://www.aihw.gov.au/publication-detail/?id=6442468375.

Australian Institute of Health and Welfare. (2010b). Mental health services in Australia 2007–2008. Mental Health Series Number 12. Cat N. HSE 88. Retrieved February 23, 2012, from http://www.aihw.gov.au/publication-detail/?id=6442468381&tab=2.

Bell, J. S., Aaltonen, S. E., Airaksinen, M. S., Volmer, D., Gharat, M. S., Muceniece, R., et al. (2010). Determinants of mental health stigma among pharmacy students in Australia, Belgium, Estonia, Finland, India and Latvia. [Comparative Study]. International Journal of Social Psychiatry, 56(1), 3–14.PubMedCrossRef

Bell, J. S., McLachlan, A. J., Aslani, P., Whitehead, P., & Chen, T. F. (2005). Community pharmacy services to optimise the use of medications for mental illness: A systematic review. Australia and New Zealand Health Policy, 2, 29–40. doi:10.1186/1743-8462-2-29.PubMedCentralPubMedCrossRef

Bell, J. S., Rosen, A., Aslani, P., Whitehead, P., & Chen, T. (2007). Developing the role of pharmacists as members of community mental health teams: Perspectives of pharmacists and mental health professionals. Research in Social and Administrative Pharmacy, 3, 392–409.PubMedCrossRef

Benrimoj, S. I., & Frommer, M. S. (2004). Commuity pharmacy in Australia. Australian Health Review, 28, 238–246.PubMedCrossRef

Black, E., Murphy, A. L., & Gardner, D. M. (2009). Community pharmacist services for people with mental illnesses: Preferences, satisfaction, and stigma. Psychiatric Services, 60(8), 1123–1127.PubMedCrossRef

Botega, N., Mann, A., Blizard, R., & Wilkinson, G. (1992). General practitioners and depression: First use of the Depression Attitude Questionnaire. International Journal of Methods in Psychiatric Research, 4, 169–180.

Brook, O. H., Stalman, W., Nieuwenhuyse, H., Bakker, B., & de Haan, M. (2005). A pharmacy-based coaching program to improve adherence to antidepressant treatment among primary care patients. Psychiatric Services, 56(4), 487–489.PubMedCrossRef

Brook, O. H., Van Hout, H. P. J., Nieuwenhuyse, H., & De Haan, M. (2003). Effects of coaching by community pharmacists on psychological symptoms of antidepressant users: A randomised controlled trial. European Neuropsychopharmacology, 13(5), 347–354. doi:10.1016/s0924-977x(03)00031-2.PubMedCrossRef

Bryant, S. G., Guernsey, B. G., Pearce, E. L., & Hokanson, J. A. (1985). Pharmacists’ perceptions of mental health care, psychiatrists, and mentally ill patients. [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.]. American Journal of Hospital Pharmacy, 42(6), 1366–1369.PubMed

Caldwell, T. M., & Jorm, A. F. (2000). Mental health nurses’ beliefs about interventions for schizophrenia and depression: A comparison with psychiatrists and the public. Australian and New Zealand Journal of Psychiatry, 34(4), 602–611.PubMedCrossRef

Cates, M. E., Burton, A. R., & Woolley, T. W. (2005). Attitudes of pharmacists toward mental illness and providing pharmaceutical care to the mentally ill. Annals of Pharmacotherapy, 39(9), 1450–1455.PubMedCrossRef

Chong, W. W., Aslani, P., & Chen, T. F. (2011). Effectiveness of interventions to improve antidepressant medication adherence: A systematic review. International Journal of Clinical Practice, 65(9), 954–975. doi:10.1111/j.1742-1241.2011.02746.x.PubMedCrossRef

Corrigan, P. W., & Watson, A. C. (2002). Understanding the impact of stigma on people with mental illness. World Psychiatry, 1(1), 16–20.PubMedCentralPubMed

Crisp, A. H., & Gelder, M. G. (2000). Stigmatisation of people with mental illness. British Journal of Psychiatry, 177, 4–7.PubMedCrossRef

Crockett, J., Taylor, S., Grabham, A., & Stanford, P. (2006). Patient outcomes following an intervention involving community pharmacists in the management of depression. Australian Journal of Rural Health, 14(6), 263–269. doi:10.1111/j.1440-1584.2006.00827.x.PubMedCrossRef

Crump, K., Boo, G., Liew, F. S., Olivier, T., So, C., Sung, J. Y., et al. (2011). New Zealand community pharmacists’ views of their roles in meeting medicine-related needs for people with mental illness. Research in Social and Administrative Pharmacy, 7(2), 122–133. doi:10.1016/j.sapharm.2010.03.006.PubMedCrossRef

Desplenter, F., Simoens, S., & Laekeman, G. (2006). The impact of informing psychiatric patients about their medication: A systematic review. Pharmacy World & Science, 28(6), 329–341. doi:10.1007/s11096-006-9054-2.CrossRef

Ewan, M. A., & Greene, R. J. (2001). Evaluation of mental health care interventions made by three community pharmacists: A pilot study. International Journal of Pharmacy Practice, 9(4), 225–234. doi:10.1111/j.2042-7174.2001.tb01053.x.CrossRef

Fan, C. (1999). A comparison of attitudes towards mental illness and knowledge of mental health services between Australian and Asian students. Community Mental Health Journal, 35(1), 47–56. doi:10.1023/a:1018795925455.PubMedCrossRef

Finley, P. R., Crismon, L., & Rush, A. J. (2003). Evaluating the impact of pharmacists in mental health: A systematic review. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 23(12), 1634–1644.CrossRef

Gardner, D., Murphy, A., Woodman, A., & Connelly, S. (2001). Community pharmacy services for antidepressant users. International Journal of Pharmacy Practice, 9(4), 217–224. doi:10.1111/j.2042-7174.2001.tb01052.x.CrossRef

George, P. P., Molina, J. A. D., Cheah, J., Chan, S. C., & Lim, B. P. (2010). The evolving role of the community pharmacist in chronic disease management: A literature review. Annals of the Academy of Medicine, Singapore, 39(11), 861–867.PubMed

Gilbert, A. L., Roughead, E. E., Beilby, J., Mott, K., & Barratt, J. D. (2002). Collaborative medication management services: Improving patient care. Medical Journal of Australia, 177, 189–192.PubMed

Gilbody, S., Bower, P., Fletcher, J., Richards, D., & Sutton, A. J. (2006). Collaborative care for depression: A cumulative meta-analysis and review of longer-term outcomes. Archives of Internal Medicine, 166(21), 2314–2321. doi:10.1001/archinte.166.21.2314.PubMedCrossRef

Gisev, N., Bell, J. S., O’Reilly, C. L., Rosen, A., & Chen, T. F. (2010). An expert panel assessment of comprehensive medication reviews for clients of community mental health teams. [Comparative Study Research Support, Non-U.S. Gov’t]. Social Psychiatry & Psychiatric Epidemiology, 45(11), 1071–1079.

Hamann, J., Cohen, R., Leucht, S., Busch, R., & Kissling, W. (2005). Do patients with schizophrenia wish to be involved in decisions about their medical treatment? [Comparative Study Research Support, Non-U.S. Gov’t]. American Journal of Psychiatry, 162(12), 2382–2384.

Hammond, R. W., Schwartz, A. H., Campbell, M. J., Remington, T. L., Chuck, S., Blair, M. M., et al. (2003). Collaborative drug therapy management by pharmacists. Pharmacotherapy, 23(9), 1210–1225.PubMedCrossRef

Happell, B., Manias, E., & Roper, C. (2004). Wanting to be heard: Mental health consumers’ experiences of information about medication. International Journal of Mental Health Nursing, 13(4), 242–248.PubMedCrossRef

Harris, D., & Anderson, C. (2003). Interventions by community pharmacists for older people with mental health problems: Are they appropriate? International Journal of Pharmacy Practice, 11(suppl), R56.

Healthcare Management Advisors. (2010). Managing mental illness and promoting and sustaining recovery: The role of community pharmacy. Retrieved April 6, 2011, from http://www.guild.org.au/iwov-resources/documents/The_Guild/PDFs/CPA%20and%20Programs/4CPA%20General/2007%2008-07/RFT0807%20MMI%20Full%20Final%20Report%20FINAL.pdf.

Hirai, M., & Clum, G. A. (2000). Development, reliability, and validity of the beliefs toward Mental Illness Scale. Journal of Psychopathology and Behavioural Assessment, 22(3), 221–236. doi:10.1023/A:1007548432472.CrossRef

Human Capital Alliance. (2008). Pharmacy workforce planning study: Initial supply report. Retrieved January 30, 2012, from http://www.humancapitalalliance.com.au/documents/PH08-Full%20Final%20Report.pdf.

Jorm, A. F., Korten, A. E., Jacomb, P. A., Christensen, H., & Henderson, S. (1999). Attitudes towards people with a mental disorder: A survey of the Australian public and health professionals. Australia and New Zealand Journal of Psychiatry, 33, 77–83. doi:10.1046/j.1440-1614.1999.00513.x.CrossRef

Jorm, A. F., Korten, A. E., Jacomb, P. A., Rodgers, B., & Pollitt, P. (1997). Beliefs about the helpfulness of interventions for mental disorders: A comparison of general practitioners, psychiatrists and clinical psychologists. Australia and New Zealand Journal of Psychiatry, 31(6), 844–851.CrossRef

Kai, J., & Crosland, A. (2001). Perspectives of people with enduring mental ill health from a community-based qualitative study. [Research Support, Non-U.S. Gov’t]. The British Journal of General Practice, 51(470), 730–736.PubMedCentralPubMed

Kassam, A., Glozier, N., Leese, M., Henderson, C., & Thornicroft, G. (2010). Development and responsiveness of a scale to measure clinicians’ attitudes to people with mental illness (medical student version). Acta Psychiatrica Scandinavica, 122(2), 153–161. doi:10.1111/j.1600-0447.2010.01562.x.PubMedCrossRef

Kobau, R., Dilorio, C., Chapman, D., Delvecchio, P., & S. C. M. I. S. P. Members. (2010). Attitudes about mental illness and its treatment: Validation of a generic scale for public health surveillance of mental illness associated stigma. Community Mental Health Journal, 46, 164–176.PubMedCrossRef

Koo, M., Krass, I., & Aslani, P. (2002). Consumer opinions on medicines information and factors affecting its use: An Australian experience. International Journal of Pharmacy Practice, 10, 107–114. doi:10.1111/j.2042-7174.2002.tb00595.x.CrossRef

Lauber, C., Nordt, C., Braunschweig, C., & Rössler, W. (2006). Do mental health professionals stigmatize their patients? Acta Psychiatrica Scandinavica, 113, 51–59. doi:10.1111/j.1600-0447.2005.00718.x.CrossRef

Lingam, R., & Scott, J. (2002). Treatment non-adherence in affective disorders. [Review]. Acta Psychiatrica Scandinavica, 105(3), 164–172.PubMedCrossRef

Link, B. G., Cullen, F. T., Frank, J., & Wozniak, J. F. (1987). The social rejection of former mental-patients: Understanding why labels matter. American Journal of Sociology, 92(6), 1461–1500.CrossRef

Mant, A., Rendle, V. A., Hall, W. D., Mitchell, P. B., Montgomery, W. S., McManus, P. R., et al. (2004). Making new choices about antidepressants in Australia: The long view 1975–2002. Medical Journal of Australia, 181(7), s21–s24.PubMed

Maslen, C. L., Rees, L., & Redfern, P. H. (1996). Role of the community pharmacist in the care of patients with chronic schizophrenia in the community. International Journal of Pharmacy Practice, 4(4), 187–195. doi:10.1111/j.2042-7174.1996.tb00867.x.CrossRef

McCall, L., Clarke, D. M., & Rowley, G. (2002). A questionnaire to measure general practitioners’ attitudes to their role in the management of patients with depression and anxiety. Australian Family Physician, 31(3), 299–303.PubMed

Meagher, D., & Moran, M. (2003). Sub-optimal prescribing in an adult community mental health service: Prevalence and determinants. Psychiatric Bulletin, 27(7), 266–270. doi:10.1192/pb.02-291.CrossRef

Mental Health Branch Queensland Health. (2008). The Queensland plan for mental health 2007-2017. Retrieved April 6, 2011, from http://www.health.qld.gov.au/mentalhealth/abt_us/qpfmh/08132_qpfmh07.pdf.

Mental Health Commission. (2004). Our lives in 2014: A recovery vision from people with experience of mental illness for the second mental health plan and the development of the health and social sectors. Retrieved 06 April, 2011, from http://www.maryohagan.com/resources/Text_Files/Our%20Lives%20in%202014.pdf.

Nordt, C., Rossler, W., & Lauber, C. (2006). Attitudes of mental health professionals towards people with schizophrenia and major depression. Schizophrenia Bulletin, 32(4), 709–714.PubMedCrossRef

O’Reilly, C., Bell, J. S., & Chen, T. F. (2010). Pharmacists’ beliefs about treatments and outcomes of mental disorders: A mental health literacy survey. Australia and New Zealand Journal of Psychiatry, 44(12), 1089–1096.CrossRef

Pharmacy Guild of Australia. (2010). The roadmap: The strategic direction for community pharmacy. Retrieved April 6, 2011, from http://www.guild.org.au/iwov-resources/documents/The_Guild/PDFs/News%20and%20Events/Publications/The%20Roadmap/Roadmap.pdf.

Pharmacy Guild of Australia. (2012). Pharmacy assistant training. Retrieved April 1, 2012, from http://www.guildtraining.com.au/sites/Guild_Training/Pharmacy%20Assistants%20Training/Pharmacy%20Assistant%20Training.page.

Phokeo, V., Sproule, B., & Raman-Wilms, L. (2004). Community pharmacists’ attitudes toward and professional interactions with users of psychiatric medication. Psychiatric Services, 55(12), 1434–1436. doi:10.1176/appi.ps.55.12.1434.PubMedCrossRef

Priest, R. G., Vize, C., Roberts, A., Roberts, M., & Tylee, A. (1996). Lay people’s attitudes to treatment of depression: Results of opinion poll for Defeat Depression Campaign just before its launch. British Medical Journal, 313, 858–859.PubMedCrossRef

SANE Media Centre. (2011). Stigma hurtful and common for people with mental illness. Retrieved January 30, 2012, from http://www.sane.org/releases-2011/1056-stigma-hurtful-and-common-for-people-with-mental-illness.

Scheerder, G., De Coster, I., & Van Audenhove, C. (2008). Pharmacists’ role in depression care: A survey of attitudes, current practices, and barriers. Psychiatric Services, 59(10), 1155–1160. doi:10.1176/appi.ps.59.10.1155.PubMedCrossRef

Scheerder, G., De Coster, I., & Van Audenhove, C. (2009). Community pharmacists’ attitude toward depression: A pilot study. Research in Social and Administrative Pharmacy, 5, 242–252. doi:10.1016/j.sapharm.2008.08.008.PubMedCrossRef

Scheerder, G., Van Audenhove, C., Arensman, E., Bernik, B., Giupponi, G., Horel, A.-C., et al. (2011). Community and health professionals’ attitude towards depression: A pilot study in nine EAAD countries. International Journal of Social Psychiatry, 57(387), 337–401. doi:10.1177/0020764009359742.

Slade, T., Johnston, A., Oakley Browne, M. A., Andrews, G., & Whiteford, H. (2009). 2007 national survey of mental health and wellbeing: Methods and key findings. Australian and New Zealand Journal of Psychiatry, 43(7), 594–605.PubMedCrossRef

Tanskanen, P., Airaksinen, M., Tanskanen, A., & Enlund, H. (2000). Counselling patients on psychotropic medication: Physicians’ opinions on the role of community pharmacists. Pharmacy World & Science, 22(2), 59–61.CrossRef

University of South Australia. (2005). Consumer experiences, needs and expectations of community pharmacy. Retrieved April 6, 2011, from http://www.guild.org.au/iwov-resources/documents/The_Guild/PDFs/CPA%20and%20Programs/3CPA%20General/2005-501/Final%20Rept_8Mar06.pdf.

Valenstein, M., Kavanagh, J., Lee, T., Reilly, P., Dalack, G. W., Grabowski, J., et al. (2011). Using a pharmacy-based intervention to improve antipsychotic adherence among patients with serious mental illness. Schizophrenia Bulletin, 37(4), 727–736.PubMedCrossRef

Van Wijk, B. L., Klungel, O. H., Heerdink, E. R., & de Boer, A. (2005). Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: A systematic review. Annals of Pharmacotherapy, 39, 1325–1330. doi:10.1345/aph.1E027.CrossRef

Volmer, D., Maesalu, M., & Bell, J. (2008). Pharmacy students’ attitudes toward and professional interactions with people with mental disorders. International Journal of Social Psychiatry, 54, 402–413.PubMedCrossRef

Wahl, O. F. (1999). Mental health consumers’ experience of stigma. Schizophrenia Bulletin, 25(3), 467–478.PubMedCrossRef

Wahl, O. F. (2011). Stigma as a barrier to recovery from mental illness. Trends in Cognitive Sciences, 16(1), 9–10. doi:10.1016/j.tics.2011.11.002.PubMedCrossRef

World Health Organization. (2001). The world health report 2001: Mental health: New understanding, new hope. Retrieved April 6, 2011, from http://www.who.int/whr/2001/en/whr01_en.pdf.

World Health Organization. (2008a). The global burden of disease: 2004 update. Retrieved April 6, 2011, from http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf.

World Health Organization. (2008b). Integrating mental health into primary care: A global perspective. Retrieved January 30, 2012, from http://whqlibdoc.who.int/publications/2008/9789241563680_eng.pdf.

World Health Organization. (2008c). Mental health gap action programme: Scaling up care for mental, neurological and substance use disorders. Retrieved April 6, 2011, from http://whqlibdoc.who.int/publications/2008/9789241596206_eng.pdf.

Yeap, R., Beevi, Z., & Lukman, H. (2008). Evaluating IMU communication skills training programme: Assessment tool development. [Evaluation Studies]. Medical Journal of Malaysia, 63(3), 244–246.PubMed

Titel: Review of Community Pharmacy Staff Educational Needs for Supporting Mental Health Consumers and Carers
verfasst von: Amary Mey
Jane L. Fowler
Kathy Knox
David H. K. Shum
Jasmina Fejzic
Laetitia Hattingh
Denise McConnell
Amanda Wheeler
Publikationsdatum: 01.01.2014
Verlag: Springer US
Erschienen in: Community Mental Health Journal / Ausgabe 1/2014
Print ISSN: 0010-3853
Elektronische ISSN: 1573-2789
DOI: https://doi.org/10.1007/s10597-012-9580-4

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2014

“It’s Good for Me”: Physical Activity in Older Adults with Schizophrenia

Factors Influencing Korean International Students’ Preferences for Mental Health Professionals: A Conjoint Analysis

Employment Specialist Competencies as Predictors of Employment Outcomes

Psychiatry Residents’ Perception of Public/Community Psychiatry Fellowship Training

The Effectiveness of Lifestyle Interventions to Reduce Cardiovascular Risk in Patients with Severe Mental Disorders: Meta-Analysis of Intervention Studies

Community Psychiatry Tracks for Residents: A Review of Four Programs